Overview

NRC licenses and regulates medical use of byproduct material including PET and SPECT radiopharmaceuticals and therapeutic isotopes.

Modality Focus

Regulations cover nuclear medicine PET SPECT radiopharmacy safe handling and radiation protection for staff and patients.

Key Rules

Part 35 medical use of byproduct material sets licensing training recordkeeping and safety program requirements.

Coordination

NRC works with state regulators and FDA on radiopharmaceutical approval and clinical use oversight.